---
schema_version: "secwatch.filing_event.v1"
accession: "0000078003-26-000087"
form_type: "8-K"
ticker: "PFE"
cik: "0000078003"
company_name: "PFIZER INC"
filed_at: "2026-06-18T17:17:22+00:00"
generated_at: "2026-06-18T17:19:06.597017+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Pfizer reaffirms FY2026 guidance after CFO transition; revenue $59.5-$62.5B, adj. EPS $2.80-$3.00

## Summary
- Reaffirms FY2026 revenue guidance of $59.5-$62.5 billion.
- Reaffirms FY2026 adjusted diluted EPS guidance of $2.80-$3.00.
- Reaffirmation follows CFO transition announcement on June 18, 2026.
- Guidance originally introduced Dec 16, 2025 and reaffirmed on Q1 2026 earnings call May 5, 2026.

## SEC filing metadata
- accession: 0000078003-26-000087
- form_type: 8-K
- ticker: PFE
- cik: 0000078003
- company_name: PFIZER INC
- filed_at: 2026-06-18T17:17:22+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/78003/000007800326000087/0000078003-26-000087-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/78003/000007800326000087/pfe-20260618.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000078003-26-000087
- JSON: https://secwatch.observer/filing/0000078003-26-000087.json
- Plain text: https://secwatch.observer/filing/0000078003-26-000087.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.